BN Business News
Add your company to Business Communicator →

Business · 26/02/1996

FDA Releases Draft Document on Regulation of Placental/Umbilical Cord Blood Stem Cell Products

The FDA is releasing a draft document outlining its approach to regulating placental/umbilical cord blood stem cell products for transplantation, inviting public comments on the proposal.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights